Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What a fantastic SHORT opp here ..Another Phase 3 is required and they running out of cash another point is tha the market is full of very very cheap generics for Migraine
there is only handful most of them are private like monosol
Oral Thin Films: Game-Changing Drug Delivery Technologies
http://www.fiercepharma.com/special-report/oral-thin-films-game-changing-drug-delivery-technologies
It was Mr Miller from IR who told me about the acquisiton , i just wanted to know why they doesnt stop the manipulation .
Dear XXXXXX,
I hear your frustration.
We are very focused on building IntelGenx into a world class leader in pharmaceutical oral films.
Just last night one of our peers was purchased for $624 million and they have one film product in their pipeline. Please see attached.
Best regards
Edward
Competitor CYNA gets bought for $624 M and they have only 1 oralfilm in their Pipeline.So you can see how brutally underpriced IGXT is with their Mega pipeline.
http://www.businesswire.com/news/home/20160831006494/en/Sunovion-Pharmaceuticals-Acquire-Cynapsus-Therapeutics
Any dip here is a great buying opportunity
look who post nr 1 and created this board before you posting garbage
IGXT has the Drug that has multi billion dollar potential so if a big pharma company wants the rights to the Drug then they have to pay for it means upfront payment ,royalties plus milestones payments and they pay the development costs . And once the Drug is on market the big pharma will earn the most money thats the normal process of a partner deal .
You guys should learn more about the Biotech Sector .
Maybe last chance to get it below $1
Possible Buyout ? Whatever very Strong accumulation ongoing and that looks fantastic
PARTNER DEAL NEWS IMMINENT
Above and beyond that, there are ongoing late-stage discussions with a global pharmaceutical company for multiple products with the potential goal of finalizing a definitive agreement in the third quarter of 2016
IGXT close to hit $1 then real rally will begin
IGXT is in discussions with 33 Pharmaceutical Companies maybe some of them wants to takeover IGXT because IGXT is a gift here with a Market Cap of ridiculous $58 Million , its much more attractive to takeover IGXT than to pay royalties at this Levels .
With respect to other BD activities, we're clearly focusing right now in the business development area on bringing in new deals. For example at the recent BIO Conference, we met with 50 different pharmaceutical companies to discuss partnering opportunities, and we're currently in discussions with eight companies that are interested in RIZAPORT licenses, 17 companies that are interested in our Tadalafil product, three companies are interested in our schizophrenia drug, and five companies have expressed interest in a deal on Forfivo outside of the US.
Above and beyond that, there are ongoing late-stage discussions with a global pharmaceutical company for multiple products with the potential goal of finalizing a definitive agreement in the third quarter of 2016
http://s2.q4cdn.com/790425727/files/doc_financials/2016/final-081116-intelgenx-q2-2016-financial-results-47950179-v.3.pdf
$7+ Stock trading at laughable 93 pennies .. This is what is called a lifetime opportunity
IGXT close to hit $1
IGXT is in discussions with 33 Pharmaceutical Companies maybe some of them wants to takeover IGXT because IGXT is a gift here with a Market Cap of ridiculous $58 Million , its much more attractive to takeover IGXT than to pay royalties at this Levels .
With respect to other BD activities, we're clearly focusing right now in the business development area on bringing in new deals. For example at the recent BIO Conference, we met with 50 different pharmaceutical companies to discuss partnering opportunities, and we're currently in discussions with eight companies that are interested in RIZAPORT licenses, 17 companies that are interested in our Tadalafil product, three companies are interested in our schizophrenia drug, and five companies have expressed interest in a deal on Forfivo outside of the US.
Above and beyond that, there are ongoing late-stage discussions with a global pharmaceutical company for multiple products with the potential goal of finalizing a definitive agreement in the third quarter of 2016
http://s2.q4cdn.com/790425727/files/doc_financials/2016/final-081116-intelgenx-q2-2016-financial-results-47950179-v.3.pdf
IGXT moving up again
IGXT is in discussions with 33 Pharmaceutical Companies maybe some of them wants to takeover IGXT because IGXT is a gift here with a Market Cap of ridiculous $58 Million , its much more attractive to takeover IGXT than to pay royalties at this Levels .
With respect to other BD activities, we're clearly focusing right now in the business development area on bringing in new deals. For example at the recent BIO Conference, we met with 50 different pharmaceutical companies to discuss partnering opportunities, and we're currently in discussions with eight companies that are interested in RIZAPORT licenses, 17 companies that are interested in our Tadalafil product, three companies are interested in our schizophrenia drug, and five companies have expressed interest in a deal on Forfivo outside of the US.
Above and beyond that, there are ongoing late-stage discussions with a global pharmaceutical company for multiple products with the potential goal of finalizing a definitive agreement in the third quarter of 2016
http://s2.q4cdn.com/790425727/files/doc_financials/2016/final-081116-intelgenx-q2-2016-financial-results-47950179-v.3.pdf
NICE move again i love it
Its one of the cheapest Biotech out there and new partner deal expected within 4 weeks .
Buying IGXT is like buying ACAD at $1 a few years ago which now trading over $30 .
Almost 19 Million Shares held by Insiders and Institutions which is great for stock trading below $1 . Most Institutional investors dont buy stock which trading below $1 .
Insider Ownership :
Horst G. Zerbe 4,670,243.5 7.34%
Ingrid Zerbe 5,471,356.5 8.60%
Bernard J. Boudreau 287,500
Bernd Melcher 232,500
Andre Godin 214,500
Ian Troup 187,500
John Marinucc 175,000
Nadine Paiement 135,000
Clemens Mayr 68,750
John Durham 50,000
Robert Bechard 10,000
All directors and officers as a group (11 persons) 11,502,351 18.08%
Institutional Holders :
Alpha Capital ...3.2M
Roadmap Capital Inc. 3.1M
IGXT (Mkap $34 M) 2 US-Zulassungsanträge im 4Q + weiteres Produkt wartet auf FDA Zulassung | wallstreet-online.de - Vollständige Diskussion unter:
http://www.wallstreet-online.de/diskussion/1235830-1-10/igxt-mkap-34-m-2-us-zulassungsantraege-4q-produkt-wartet-fda-zulassung
IGXT close to hit $1 Mark then real rally will begin ....
MoreInfos about this undiscovered Goldmine :
(IGXT) = Mcap $55 M /Cash till mid 2018/ 2 NDA Submissions in expected early 1Q /1 Big Drug awaiting FDA approval/ Multiple Partner Deals imminent = LIFETIME OPPORTUNITY ..1000%+ GEM
´
Undiscovered Intelgenx (IGXT) is definitely one of the most attractive and undervalued stock in the Biotech Sector . The Company has already 2 Drugs approved and another 2 Big Drugs close to FDA approval .BIG Partnership News could come any day for up to 3 Drugs for which IGXT got a Therm Sheet from a Global Pharma Company and there are partnering discussion ongoing for several Drugs .Their unique Thin-film version of the Blockbuster Drug Cialis (Erectile Dysfunction) alone is worth $2-3 per share , NDA filing for the Drug expected in early Q1 2017.
IGXT has a ridiculous Market Cap of US$55 Million which is a Big Joke for a Company with such a MEGA Product Pipeline , this Co has everything to be the next 10 Bagger minimum .GL
Intelgenx (IGXT)
Market Cap: $55 Million
Cash: $7.1 Million
Price: 0.86
Burn-Rate: ~$400k per Quarter
Shares Out : 63.6 Million
Upcoming Milestones :
"Continued late-stage discussions with global pharmaceutical companies for multiple products with the potential goal of concluding a definitive agreement to be finalized in the third quarter of 2016"
Product :Indicated for Opioid Dependence
•Awaiting FDA approval
•According to IMS data, the oral film market for opioid dependence was worth more than $1.4B US in 2014.
Product :Rizaport (Migraine)
•European Mktg Approval–November 2015
•Planned USA re-submission to FDA Q1/2017
•Expected USA launch Q2-Q3/2017
Product :Tadalafil (Erectile Dysfunction)
•505(b)(2) USA NDA submission in Q1/2017
•Expected USA launch Q1/2018
Wafer Viagra For Instant Results One of the big challenges for erectile dysfunction medicine manufacturers is to quicken the time between the application of the medicine and its response. Men want instant results when they take Viagra, Cialis or Levitra and complain that having to wait as much as thirty minutes before the active ingredient is effective can burst the bubble of spontaneity and passion which are often essential requirements of good sex. Well a solution could be at hand following research done by a Canadian research company called IntelGenx who have developed wafers [like the common breath freshness ones] that are designed to melt on your tongue which they say will get the medicine into your bloodstream around 30% faster than by using conventional tablets. IntelGenx say that because the mouth is lined with tiny blood vessels applying the wafer Viagra here can give a very fast application of the drug directly into the bloodstream. IntelGenx said that they would be conducting more clinical trials to corroborate this and they hoped to develop a whole range of fast acting wafer medications to treat not only erectile dysfunction but also pain relief, depression and hypertension. Sometimes men complain that if they have eaten a large meal it can take an even longer time for the Viagra, Cialis and Levitra to take effect. If on the other hand they made use of erectile dysfunction medication in a wafer form applied directly to the mouth and therefore bypassing their digestive system this problem would disappear. Using a wafer type of Viagra would also mean that you wouldn't have to go and get a glass of water in the middle of a passionate encounter in order to swallow your pill. Wafer Viagra would be a much more discreet application of impotence medication and Ukmedix News will be looking out for updates on the IntelGenx clinical testing done on this new idea.
IntelGenx Technologies Corp (OTCMKTS:IGXT) Is Today’s Pharma Focus
http://www.insiderfinancial.com/intelgenx-technologies-corp-otcmktsigxt-is-todays-pharma-focus/116698/
Currently trading with a market cap of $39 million, IGXT is one OTC pharma stock that has a lot in the pipeline. All it needs is one product to hit, and the company will be worth 10x its current market cap. IGXT has multi-bagger written all over it.
IGXT close to break $1 then real Rally will begin
(IGXT) = Mcap $55 M /Cash till mid 2018/ 2 NDA Submissions in expected early 1Q /1 Big Drug awaiting FDA approval/ Multiple Partner Deals imminent = LIFETIME OPPORTUNITY ..1000%+ GEM
´
Undiscovered Intelgenx (IGXT) is definitely one of the most attractive and undervalued stock in the Biotech Sector . The Company has already 2 Drugs approved and another 2 Big Drugs close to FDA approval .BIG Partnership News could come any day for up to 3 Drugs for which IGXT got a Therm Sheet from a Global Pharma Company and there are partnering discussion ongoing for several Drugs .Their unique Thin-film version of the Blockbuster Drug Cialis (Erectile Dysfunction) alone is worth $2-3 per share , NDA filing for the Drug expected in early Q1 2017.
IGXT has a ridiculous Market Cap of US$55 Million which is a Big Joke for a Company with such a MEGA Product Pipeline , this Co has everything to be the next 10 Bagger minimum .GL
Intelgenx (IGXT)
Market Cap: $55 Million
Cash: $7.1 Million
Price: 0.86
Burn-Rate: ~$400k per Quarter
Shares Out : 63.6 Million
Upcoming Milestones :
"Continued late-stage discussions with global pharmaceutical companies for multiple products with the potential goal of concluding a definitive agreement to be finalized in the third quarter of 2016"
Product :Indicated for Opioid Dependence
•Awaiting FDA approval
•According to IMS data, the oral film market for opioid dependence was worth more than $1.4B US in 2014.
Product :Rizaport (Migraine)
•European Mktg Approval–November 2015
•Planned USA re-submission to FDA Q1/2017
•Expected USA launch Q2-Q3/2017
Product :Tadalafil (Erectile Dysfunction)
•505(b)(2) USA NDA submission in Q1/2017
•Expected USA launch Q1/2018
Wafer Viagra For Instant Results One of the big challenges for erectile dysfunction medicine manufacturers is to quicken the time between the application of the medicine and its response. Men want instant results when they take Viagra, Cialis or Levitra and complain that having to wait as much as thirty minutes before the active ingredient is effective can burst the bubble of spontaneity and passion which are often essential requirements of good sex. Well a solution could be at hand following research done by a Canadian research company called IntelGenx who have developed wafers [like the common breath freshness ones] that are designed to melt on your tongue which they say will get the medicine into your bloodstream around 30% faster than by using conventional tablets. IntelGenx say that because the mouth is lined with tiny blood vessels applying the wafer Viagra here can give a very fast application of the drug directly into the bloodstream. IntelGenx said that they would be conducting more clinical trials to corroborate this and they hoped to develop a whole range of fast acting wafer medications to treat not only erectile dysfunction but also pain relief, depression and hypertension. Sometimes men complain that if they have eaten a large meal it can take an even longer time for the Viagra, Cialis and Levitra to take effect. If on the other hand they made use of erectile dysfunction medication in a wafer form applied directly to the mouth and therefore bypassing their digestive system this problem would disappear. Using a wafer type of Viagra would also mean that you wouldn't have to go and get a glass of water in the middle of a passionate encounter in order to swallow your pill. Wafer Viagra would be a much more discreet application of impotence medication and Ukmedix News will be looking out for updates on the IntelGenx clinical testing done on this new idea.
IntelGenx Technologies Corp (OTCMKTS:IGXT) Is Today’s Pharma Focus
http://www.insiderfinancial.com/intelgenx-technologies-corp-otcmktsigxt-is-todays-pharma-focus/116698/
Currently trading with a market cap of $39 million, IGXT is one OTC pharma stock that has a lot in the pipeline. All it needs is one product to hit, and the company will be worth 10x its current market cap. IGXT has multi-bagger written all over it.
getting closer and closer to the $1 Mark
MAJOR Breakout to $1++ could start anytime now
$1++ is possible this week
PARTNER DEAL NEWS around the corner
New Presenation out shows that there is already strong Pharma interest in Montelukast after positive results (page 13) .We have a MEGA Pipeline ,a lot of Cash for 2 Years and many Drugs close to NDA Submissions all this for a brutal terrible low valuation of $50 Million .IGXT is definitely a MUST HAVE at these levels and patience will payoff big time here thats for sure .
http://s2.q4cdn.com/790425727/files/doc_presentations/2016/IGXT-Aug-22-Investor-Presentation.pdf
New Presenation out shows that there is already strong Pharma interest in Montelukast after positive results (page 13) .We have a MEGA Pipeline ,a lot of Cash for 2 Years and many Drugs close to NDA Submissions all this for a brutal terrible low valuation of $50 Million .IGXT is definitely a MUST HAVE at these levels and patience will payoff big time here thats for sure .
http://s2.q4cdn.com/790425727/files/doc_presentations/2016/IGXT-Aug-22-Investor-Presentation.pdf
New Presenation out shows that there is already strong interest in Montelukast after positive results (page 13) .We have a MEGA Pipeline ,a lot of Cash for 2 Years and many Drugs close to NDA Submissions all this for a brutal terrible low valuation of $50 Million .IGXT is definitely a MUST HAVE at these levels and patience will payoff big time here thats for sure .
http://s2.q4cdn.com/790425727/files/doc_presentations/2016/IGXT-Aug-22-Investor-Presentation.pdf
Pullback creates great buying opp , Partner deal is around the corner
•Announced a development and commercialization term sheet with a global pharmaceutical company for up to three products. If entered into, IntelGenx expects the definitive agreement to be finalized in the second quarter of 2016
IGXT is in discussions with 33 Pharmaceutical Companies maybe some of them wants to takeover IGXT because IGXT is a gift here with a Market Cap of ridiculous $50 Million , its much more attractive to takeover IGXT than to pay royalties at this Levels .
http://s2.q4cdn.com/790425727/files/doc_financials/2016/final-081116-intelgenx-q2-2016-financial-results-47950179-v.3.pdf
With respect to other BD activities, we're clearly focusing right now in the business development area on bringing in new deals. For example at the recent BIO Conference, we met with 50 different pharmaceutical companies to discuss partnering opportunities, and we're currently in discussions with eight companies that are interested in RIZAPORT licenses, 17 companies that are interested in our Tadalafil product, three companies are interested in our schizophrenia drug, and five companies have expressed interest in a deal on Forfivo outside of the US.
Above and beyond that, there are ongoing late-stage discussions with a global pharmaceutical company for multiple products with the potential goal of finalizing a definitive agreement in the third quarter of 2016
Get some guys before she breaks the $1 Mark then real Rally will begin
IGXT is in discussions with 33 Pharmaceutical Companies maybe some of them wants to takeover IGXT because IGXT is a gift here with a Market Cap of ridiculous $50 Million , its much more attractive to takeover IGXT than to pay royalties at this Levels .
-----
With respect to other BD activities, we're clearly focusing right now in the business development area on bringing in new deals. For example at the recent BIO Conference, we met with 50 different pharmaceutical companies to discuss partnering opportunities, and we're currently in discussions with eight companies that are interested in RIZAPORT licenses, 17 companies that are interested in our Tadalafil product, three companies are interested in our schizophrenia drug, and five companies have expressed interest in a deal on Forfivo outside of the US.
IGXT is in discussions with 33 Pharmaceutical Companies maybe some of them wants to takeover IGXT because IGXT is a gift here with a Market Cap of ridiculous $50 Million , its much more attractive to takeover IGXT than to pay royalties at this Levels .
-----
With respect to other BD activities, we're clearly focusing right now in the business development area on bringing in new deals. For example at the recent BIO Conference, we met with 50 different pharmaceutical companies to discuss partnering opportunities, and we're currently in discussions with eight companies that are interested in RIZAPORT licenses, 17 companies that are interested in our Tadalafil product, three companies are interested in our schizophrenia drug, and five companies have expressed interest in a deal on Forfivo outside of the US.
Load up before Partner Deal news hit the wire which is expected within 4 weeks
$1++ still likely this week
MM criminals create another mega buying opportunity here
RALLYYYYYYYYYYYYY BIG NEWS OUT.....Market cap still at laughable $53 Million
IntelGenx Announces Successful Clinical Study for Montelukast for the Treatment of Degenerative Diseases of the BrainAugust 22, 2016
August 22, 2016
http://www.intelgenx.com/investors/press-releases/press-release-details/2016/IntelGenx-Announces-Successful-Clinical-Study-for-Montelukast-for-the-Treatment-of-Degenerative-Diseases-of-the-Brain/default.aspx
"We are very pleased by the results of the study which confirmed that our Montelukast VersaFilm™ significantly improves the bioavailability of the drug when given as an oral film product. The study demonstrates that the VersaFilm™ technology is an effective delivery system for CNS applications," said Dr. Horst G. Zerbe, President and CEO of IntelGenx. "Montelukast is an important drug repurposing opportunity that the company has in its product pipeline which could potentially become a multi-billion-dollar product in the large and underserved market for degenerative diseases of the brain."
NEXT BIG NEWS IS AROUND THE CORNER
Continued late-stage discussions with global pharmaceutical companies for multiple products with the potential goal of concluding a definitive agreement to be finalized in the third quarter of 2016
RALLYYYYYYYYYYYYY BIG NEWS OUT.....Market cap still at laughable $53 Million
IntelGenx Announces Successful Clinical Study for Montelukast for the Treatment of Degenerative Diseases of the BrainAugust 22, 2016
August 22, 2016
http://www.intelgenx.com/investors/press-releases/press-release-details/2016/IntelGenx-Announces-Successful-Clinical-Study-for-Montelukast-for-the-Treatment-of-Degenerative-Diseases-of-the-Brain/default.aspx
"We are very pleased by the results of the study which confirmed that our Montelukast VersaFilm™ significantly improves the bioavailability of the drug when given as an oral film product. The study demonstrates that the VersaFilm™ technology is an effective delivery system for CNS applications," said Dr. Horst G. Zerbe, President and CEO of IntelGenx. "Montelukast is an important drug repurposing opportunity that the company has in its product pipeline which could potentially become a multi-billion-dollar product in the large and underserved market for degenerative diseases of the brain."
NEXT BIG NEWS IS AROUND THE CORNER
Continued late-stage discussions with global pharmaceutical companies for multiple products with the potential goal of concluding a definitive agreement to be finalized in the third quarter of 2016
reason is the mm manipulation which tried hard to keep this stock down but this is a monster opportunity for those who like biotechs .
Next news is Partner deal for 3 Drugs coming within 4 weeks .
BIG NEWSSSSSSSSSSSSSSSSSSSSSSS OUT
http://www.intelgenx.com/investors/press-releases/press-release-details/2016/IntelGenx-Announces-Successful-Clinical-Study-for-Montelukast-for-the-Treatment-of-Degenerative-Diseases-of-the-Brain/default.aspx
IntelGenx Announces Successful Clinical Study for Montelukast for the Treatment of Degenerative Diseases of the Brain
August 22, 2016
"We are very pleased by the results of the study which confirmed that our Montelukast VersaFilm™ significantly improves the bioavailability of the drug when given as an oral film product. The study demonstrates that the VersaFilm™ technology is an effective delivery system for CNS applications," said Dr. Horst G. Zerbe, President and CEO of IntelGenx. "Montelukast is an important drug repurposing opportunity that the company has in its product pipeline which could potentially become a multi-billion-dollar product in the large and underserved market for degenerative diseases of the brain."
Next week $1++ rallyyyyyyyyyyy
Load up some guys this is a lifetime opportunity this stock is terrible brutally undervalued at current market cap of $47 million